InvestorsHub Logo
Boards
News
Market Data
Markets
Discover
Discover
Subscribe Login/Register
S&P 500
5,127.79
(
1.26%
)
US TECH 100
17,446.00
(
2.17%
)
Dow Jones
38,675.68
(
1.18%
)
Brent Oil
82.77
(
0.00%
)
Bitcoin
63,502.86
(
0.96%
)
Post# of 617044
Next 10
Reply Private New
Public Reply Private Reply New Post
Keep Last Read
Replies (1) Keep Next 10 Report Keyboard Shortcuts
Replies (1) Next 10 Prev Next

mick

Send PM Follow Ignore
Followers 3156
Posts 961240
Boards Moderated 204
Alias Born 09/04/2000

mick

Member Level

Re: 02opida post# 497835

Monday, 05/20/2019 10:19:35 PM

Monday, May 20, 2019 10:19:35 PM

Post# of 617044
suggest interest in the energy, pharmaceutical and tech industries. He's shown a particular focus on small-cap biotech stocks like Akebia Therapeutics (AKBA).

According to the latest filings, Klarman has kept a similar focus, purchasing shares of multibillion-dollar pharma companies and consumer entertainment conglomerates. Curiously, several are merger candidates.

Here are four picks from the guru's most recent public filings.
Public Reply Private Reply New Post
Keep Last Read
Replies (1) Keep Last Read Next 10 Report Keyboard Shortcuts
Replies (1) Next 10 Prev Next

Join the InvestorsHub Community

Register for free to join our community of investors and share your ideas. You will also get access to streaming quotes, interactive charts, trades, portfolio, live options flow and more tools.

Sign Up